| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1049-1058, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
RI Brody, T Ueda, A Hamelin, SC Jhanwar, JA Bridge, JH Healey, AG Huvos, WL Gerald and M Ladanyi
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
The pathogenesis of myxoid chondrosarcoma (CS) is poorly understood. A recurrent translocation, t(9;22) (q22;q12), has been recognized in CS, specifically in extraskeletal myxoid CS. Recently, this translocation has been shown to represent a rearrangement of the EWS gene at 22q12 with a novel gene at 9q22 designated CHN (or TEC). Sequence analysis suggests that CHN encodes a novel orphan nuclear receptor with a zinc finger DNA-binding domain. The structure of this gene fusion has been characterized in only a limited number of extraskeletal myxoid CSs and its presence in other types of CS has not been extensively examined. We studied 46 cases of CS (8 extraskeletal myxoid, 4 skeletal myxoid, 4 mesenchymal, and 30 other) for the EWS/CHN gene fusion by reverse transcriptase polymerase chain reaction, Southern blotting, and long- range DNA polymerase chain reaction. The EWS/CHN gene fusion was present in 6 of 8 extraskeletal myxoid CSs and was not detected in any of the remaining cases, including the 4 skeletal myxoid CSs. The negative findings in the latter cases suggest that skeletal myxoid CS is pathogenetically distinct from its extraskeletal counterpart. Notably, 2 cases of extraskeletal myxoid CS showed neither an EWS/CHN fusion transcript nor EWS/CHN genomic fusion nor EWS or CHN genomic rearrangement, suggesting genetic heterogeneity within extraskeletal myxoid CS. Finally, we also provide evidence for alternative splicing of the 3' end of the fusion transcript. Extraskeletal myxoid CS thus represents yet another sarcoma type containing a gene fusion involving EWS.
This article has been cited by other articles:
 |
|
 |
|
  J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses J. Immunol., July 1, 2005; 175(1): 555 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Chang and V. B. Shidham Molecular Genetics of Pediatric Soft Tissue Tumors: Clinical Application J. Mol. Diagn., August 1, 2003; 5(3): 143 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Shing, D. J. McMullan, P. Roberts, K. Smith, S.-F. Chin, J. Nicholson, R. M. Tillman, P. Ramani, C. Cullinane, and N. Coleman FUS/ERG Gene Fusions in Ewing's Tumors Cancer Res., August 1, 2003; 63(15): 4568 - 4576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sjogren, J. M. Meis-Kindblom, C. Orndal, P. Bergh, K. Ptaszynski, P. Aman, L.-G. Kindblom, and G. Stenman Studies on the Molecular Pathogenesis of Extraskeletal Myxoid Chondrosarcoma--Cytogenetic, Molecular Genetic, and cDNA Microarray Analyses Am. J. Pathol., March 1, 2003; 162(3): 781 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. McEvoy, E. A. Murphy, T. Ponnio, O. M. Conneely, B. Bresnihan, O. FitzGerald, and E. P. Murphy Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-{kappa}B and Cyclic Adenosine 5'-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue J. Immunol., March 15, 2002; 168(6): 2979 - 2987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ponnio, Q. Burton, F. A. Pereira, D. K. Wu, and O. M. Conneely The Nuclear Receptor Nor-1 Is Essential for Proliferation of the Semicircular Canals of the Mouse Inner Ear Mol. Cell. Biol., February 1, 2002; 22(3): 935 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. de Alava and J. Pardo Ewing Tumor: Tumor Biology and Clinical Applications International Journal of Surgical Pathology, January 1, 2001; 9(1): 7 - 17. [Abstract] [PDF]
|
|
|
|
|
|
H. Sjögren, B. Wedell, J. M. M. Kindblom, L.-G. Kindblom, and G. Stenman Fusion of the NH2-Terminal Domain of the Basic Helix-Loop-Helix Protein TCF12 to TEC in Extraskeletal Myxoid Chondrosarcoma with Translocation t(9;15)(q22;q21) Cancer Res., December 1, 2000; 60(24): 6832 - 6835. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Oshiro, H. Shiratsuchi, S. Tamiya, Y. Oda, S. Toyoshima, and M. Tsuneyoshi Extraskeletal Myxoid Chondrosarcoma with Rhabdoid Features, with Special Reference to Its Aggressive Behavior International Journal of Surgical Pathology, April 1, 2000; 8(2): 145 - 152. [Abstract] [PDF]
|
|
|
|
|
|
H. Sjogren, J. Meis-Kindblom, L.-G. Kindblom, P. Aman, and G. Stenman Fusion of the EWS-related Gene TAF2N to TEC in Extraskeletal Myxoid Chondrosarcoma Cancer Res., October 1, 1999; 59(20): 5064 - 5067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Palmer, P. North, R. W. Nicholas, J. W. Allison, and D. M. Parham Pathologic Case of the Month Arch Pediatr Adolesc Med, October 1, 1999; 153(10): 1107 - 1108. [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Knoop and S. J. Baker The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation J. Biol. Chem., August 4, 2000; 275(32): 24865 - 24871. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
